CARGO Therapeutics, Inc. (CRGX)
Aug 19, 2025 - CRGX was delisted (reason: acquired by Concentra Biosciences)
4.470
-0.070 (-1.54%)
Inactive · Last trade price on Aug 18, 2025

CARGO Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for CARGO Therapeutics stock had an average target of 5.33, with a low estimate of 4.00 and a high estimate of 7.00.

Price Target: $5.33 (+19.24%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$4.00$5.33$5.00$7.00
Change-10.51%+19.24%+11.86%+56.60%
* Price targets were last updated on Jul 8, 2025.

Analyst Ratings

The average analyst rating for CARGO Therapeutics stock from 7 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy000000
Buy000000
Hold666666
Sell111111
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Hold
Maintains
$3.7$5
HoldMaintains$3.7$5+11.86%Jul 8, 2025
Truist Securities
Truist Securities
Hold
Downgrades
$32$7
HoldDowngrades$32$7+56.60%Jan 30, 2025
Piper Sandler
Piper Sandler
Hold
Downgrades
$34$4
HoldDowngrades$34$4-10.51%Jan 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJan 30, 2025
JP Morgan
JP Morgan
Sell
Downgrades
n/a
SellDowngradesn/an/aJan 30, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.86
from -3.72
EPS Next Year
-2.41
from -2.86
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
-------
Revenue Growth
-------
EPS
-38.38-104.40-16.53-3.72-2.86-2.41-2.56
EPS Growth
-------
Forward PE
-------
No. Analysts
----986
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-1.56-0.66
Avg-2.86-2.41
Low-4.31-4.70

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.